Related references
Note: Only part of the references are listed.High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer
Eriko Katsuta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts
Maiko Okano et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2020)
Myeloid-driven mechanisms as barriers to antitumor CD8+ T cell activity
Sean H. Colligan et al.
MOLECULAR IMMUNOLOGY (2020)
Choosing The Right Animal Model for Renal Cancer Research
Pawel Sobczuk et al.
TRANSLATIONAL ONCOLOGY (2020)
Novel Breast Cancer Brain Metastasis Patient-Derived Orthotopic Xenograft Model for Preclinical Studies
Masanori Oshi et al.
CANCERS (2020)
Biologically Aggressive Phenotype and Anti-cancer Immunity Counterbalance in Breast Cancer with High Mutation Rate
Hideo Takahashi et al.
SCIENTIFIC REPORTS (2020)
High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer
Yoshihisa Tokumaru et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Pancreatic adenocarcinomas with mature blood vessels have better overall survival
Eriko Katsuta et al.
SCIENTIFIC REPORTS (2019)
Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
Yuxin Lin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer
Peiwen Ma et al.
FRONTIERS IN IMMUNOLOGY (2019)
Extracellular adenosine promotes cell migration/invasion of Glioblastoma Stem-like Cells through A3 Adenosine Receptor activation under hypoxia
Angelo Torres et al.
CANCER LETTERS (2019)
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
T lymphocyte subsets in cancer immunity: Friends or foes
Dounia Chraa et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
Expression of MicroRNA-9 is Associated With Overall Survival in Breast Cancer Patients
Judith C. Sporn et al.
JOURNAL OF SURGICAL RESEARCH (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
IFN regulatory factor-8 expression in macrophages governs an antimetastatic program
Danielle Y. F. Twum et al.
JCI INSIGHT (2019)
Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis
Masayuki Nagahashi et al.
CANCER RESEARCH (2018)
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
David F. McDermott et al.
NATURE MEDICINE (2018)
High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy
Tomoaki Terakawa et al.
Oncotarget (2018)
Generation of sphingosine-1-phosphate is enhanced in biliary tract cancer patients and is associated with lymphatic metastasis
Yuki Hirose et al.
SCIENTIFIC REPORTS (2018)
Targeting adenosine for cancer immunotherapy
Robert D. Leone et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
Jie Lan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Mouse Models for Cancer Immunotherapy Research
Brian Olson et al.
CANCER DISCOVERY (2018)
Tumor-associated macrophages: from basic research to clinical application
Li Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Murine breast cancer mastectomy model that predicts patient outcomes for drug development
Eriko Katsuta et al.
JOURNAL OF SURGICAL RESEARCH (2017)
Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer
Eriko Katsuta et al.
JOURNAL OF SURGICAL RESEARCH (2017)
Lomustine and Bevacizumab in Progressive Glioblastoma
Wolfgang Wick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Targeting immunosuppressive adenosine in cancer
D. Vijayan et al.
NATURE REVIEWS CANCER (2017)
Tumor angiogenesis and vascular normalization: alternative therapeutic targets
Claire Viallard et al.
ANGIOGENESIS (2017)
Mechanisms overseeing myeloid-derived suppressor cell production in neoplastic disease
Colleen S. Netherby et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
Rakesh R. Ramjiawan et al.
ANGIOGENESIS (2017)
Tumor microenvironment and therapeutic response
Ting Wu et al.
CANCER LETTERS (2017)
Angiopoietin pathway gene expression associated with poor breast cancer survival
Rajesh Ramanathan et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
CD73 as a therapeutic target for pancreatic neuroendocrine tumor stem cells
Eriko Katsuta et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
Peter Savas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer
Muhammad Wasif Saif et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer
George Plitas et al.
IMMUNITY (2016)
Modified breast cancer model for preclinical immunotherapy studies
Eriko Katsuta et al.
JOURNAL OF SURGICAL RESEARCH (2016)
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Takuro Saito et al.
NATURE MEDICINE (2016)
Macrophages and Therapeutic Resistance in Cancer
Brian Ruffell et al.
CANCER CELL (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma
Jinyan Liu et al.
ONCOTARGET (2015)
Animal models for exploring the pharmacokinetics of breast cancer therapies
Omar M. Rashid et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
An improved syngeneic orthotopic murine model of human breast cancer progression
Omar M. Rashid et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Regulatory T cells in cancer immunotherapy
Hiroyoshi Nishikawa et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Export of sphingosine-1-phosphate and cancer progression
Kazuaki Takabe et al.
JOURNAL OF LIPID RESEARCH (2014)
Current concepts in clinical radiation oncology
Michael Orth et al.
RADIATION AND ENVIRONMENTAL BIOPHYSICS (2014)
Lymphangiogenesis and lymphatic vessel remodelling in cancer
Steven A. Stacker et al.
NATURE REVIEWS CANCER (2014)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma
Edmund A. Mroz et al.
ORAL ONCOLOGY (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Immunity, inflammation and cancer: a leading role for adenosine
Luca Antonioli et al.
NATURE REVIEWS CANCER (2013)
NF-κB Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells
Ravikumar Muthuswamy et al.
CANCER RESEARCH (2012)
Sphingosine-1-Phosphate Produced by Sphingosine Kinase 1 Promotes Breast Cancer Progression by Stimulating Angiogenesis and Lymphangiogenesis
Masayuki Nagahashi et al.
CANCER RESEARCH (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Lymphangiogenesis: A new player in cancer progression
Masayuki Nagahashi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Lung Cancer A Systematic Review with Meta-Analysis
Ping Zhan et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression
Jean-Philippe Cosse et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
"Inside-Out" Signaling of Sphingosine-1-Phosphate: Therapeutic Targets
K. Takabe et al.
PHARMACOLOGICAL REVIEWS (2008)
How regulatory T cells work
Dario A. A. Vignali et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200
Bruce J. Giantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Opinion - Angiogenesis: an organizing principle for drug discovery?
Judah Folkman
NATURE REVIEWS DRUG DISCOVERY (2007)
Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature
G. Des Guetz et al.
BRITISH JOURNAL OF CANCER (2006)
Share Paper
